RT-PCR in acute promyelocytic leukemia: Second workshop of the European Retinoic Group

Leukemia

Volumn 10, Issue 2, 1996, Pages 368-371

  Chomienne, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

APL; PML RAR ; RT PCR

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME TRANSLOCATION 15; CONFERENCE PAPER; DNA TRANSCRIPTION; GENE AMPLIFICATION; HUMAN; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030009694     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Larson RA et al. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia, Am J Med 1984; 76: 827-841.
2. Chomienne C et al. Differentiation of acute promyelocytic cells by all-trans retinoic acid: II. In vitro studies: Structure-function relationships. Blood 1990; 76: 1710-1717.
3. Castaigne S et al. All-trans retinoic acid is a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 1990; 76: 1704-1709.
4. Chomienne C et al. The retinoic acid receptor α is rearranged in the retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990; 4: 802-807.
5. de Thé H et al. The PML-RARa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675-684.
6. Borrow J et al. Diagnosis of acute promyelocytic leukemia by RT- PCR; detection of PML-RARa and RARa-PML fusion protein transcripts. Br J Haematol 1992; 82: 529-540.
7. Pandolfi P et al. EMBO J 1992; 11: 1397-1407.
8. Castaigne S et al. A PML-RARa fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110-3115.
9. Biondi A et al. Molecular monitoring of the myl/retinoic acid receptor alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492-497.
10. Miller WH et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for PML-RARa fusion mRNA. Blood 1993; 82: 1689-1694.
11. Chen SJ et al. Occurrence of distinct PML-RARa fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 1992; 7: 1223-1232.
12. Huang W et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264-1269.
13. Diverio D et al. Absence of reverse transcription-polymerase chain reaction detectable residual diseases in patients with acute promyelocytic leukemia in long-term remission. Blood 1993; 82: 3556-3559.
14. Diverio D et al. Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 1994; 8: 1105-1107.
15. Fukutani H et al. Prognostic significance of the RT-PCR assay of PML-RARa transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho) Leukemia 1995, 9: 588-393.
16. Ikeda K et al. Reverse transcription polymerase chain reaction for PML-RARa fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia 1993, 7: 544-548.
17. Matsuoka A et al. Unexpected heterogeneity of PML-RARa fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemia. Leukemia 1993; 7: 1151-1155
18. Laczika K et al. Rapid achievement of PML-RAR polymerase chain reaction (PCR)-negativity by combined treatment with all-trans retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. Leukemia 1994, 8: 1-5.
19. Levine K, DeBlasio A, Miller WH Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid. Leukemia 1994; 8 (Suppl. 1): 116-120.
20. Delva L et al. Resistance to all-trans retinoic acid therapy in relapsing acute promyelocytic leukemia. Blood 1993; 82: 2175-2181.
21. Cornic M et al. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in promyelocytic patients. Cancer Res 1992; 53: 3329-3334.
22. Kakizuka A et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663-674.
23. Rousselot P, Hardas B, Patel A, Guidez F, Gakeu J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F, Chomienne C. The PML/RARα gene product of the t(15;17) translocation inhibits retinoic acid induced differentiation and mediated transactivation in human myeloid cells. Oncogene 1994; 9: 545-551.